In today's increasingly competitive market, efficient response and exceptional cost-performance have become crucial for ...

Health Canada begins a priority review of semaglutide 2.4 mg, a weekly treatment by Novo Nordisk for MASH, a liver disease ...

Novo Nordisk's collaboration with telehealth providers offers semaglutide at $499/month, enhancing access for self-paying ...

Of the total ER visits, nearly 70% involved GI issues, 15% of which led to hospitalization, according to a new study.

Effective July 1, 2025, CVS Caremark will place Wegovy injection 2.4 mg as preferred on its commercial template formularies.

Novo Nordisk has teamed up with Hims & Hers Health, LifeMD and Ro for cash-paying patients to access Wegovy injection 2.4 mg ...

Just today, this drug became more widely available. Some product is now facing a recall following an apparent storage error.

PLAINSBORO, N.J., April 29, 2025 /PRNewswire/ -- Today, Novo Nordisk announced it is expanding patient access to Wegovy ® (semaglutide) injection ... loss in its premium pen delivery device ...

Aussies have been warned to think before they jab, with more counterfeit Ozempic-labelled products seized at the border.

Discover the details about Wegovy, a popular weight loss drug now available for telehealth purchase. Understand its benefits, ...

You’ll use each pen once and won’t need to attach ... A 2021 study compared a 1-milligram weekly injection of semaglutide to a 2-milligram dose in over 900 people with type 2 diabetes.